Visagar Polytex Plans 100:1 Share Consolidation and ₹6 Crore Preferential Issue

Proposed consolidation ratio: 100 existing reduced shares into 1 equity share.
Preferential issue: 3 crore shares plus 3 crore warrants at ₹1 each, implying up to ₹6 crore.

Reader Takeaway: Fresh capital may support revival, but NCLT approval and dilution are the key shareholder risks.

What just happened

Visagar Polytex Limited has approved a draft Composite Scheme of Arrangement covering reduction and consolidation of its equity capital.

The company proposes to reduce its issued, subscribed and paid-up equity share capital under Section 66 of the Companies Act to write off accumulated losses and adjust the Share Forfeiture Account.

After the reduction, the remaining shares will be consolidated in a 100:1 ratio so that the face value is restored to ₹1 per equity share.

Why this matters

The restructuring is designed to align the company's paid-up capital more closely with its available net assets and simplify the share-capital structure.

For shareholders, however, the important point is that the consolidation does not itself create economic value. The eventual impact will depend on the company's revival efforts and how effectively fresh capital is deployed after the scheme becomes effective.

Preferential issue details

Visagar Polytex also plans to issue 3 crore equity shares at ₹1 each, raising ₹3 crore.

A further 3 crore warrants are proposed at ₹1 each. Warrant subscribers will pay 25%, or an aggregate ₹75 lakh, upfront, with the remaining 75% payable on exercise within 18 months.

If all warrants are exercised, the combined equity and warrant issuance would bring in up to ₹6 crore.

The preferential issue is intended to take effect after completion of the capital reduction and consolidation scheme.

What changes now

The fresh issuance will alter the company's shareholding structure. Existing investors should monitor the number of shares outstanding after the 100:1 consolidation and the dilution created by the new equity and any subsequent warrant conversions.

The board has also taken note of the resignation of statutory auditor Bhatter & Associates. Riddhi Kishor Trivedi has been appointed to fill the casual vacancy, subject to shareholder approval at the 43rd AGM.

Risks to watch

The scheme remains dependent on approval from the National Company Law Tribunal. Until the required approvals are secured and the arrangement becomes effective, the restructuring is not complete.

Dilution is another important risk. Three crore new equity shares will be issued, with a further three crore shares potentially arising from warrant conversion.

The fundraising forms part of a stated revival plan, so investors will also need to track whether the capital infusion translates into improved operations and financial performance.

What to track next

The key milestones are NCLT approval, effectiveness of the capital reduction and 100:1 consolidation, allotment of the preferential shares, and eventual exercise of warrants.

Any disclosure on the identity of allottees, post-issue shareholding, use of proceeds and operating recovery will be important for assessing the real impact on existing shareholders.